Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Cassava Sciences Inc (FLNA) vs Plug Power Inc (PLUG) Price & Performance

Cassava Sciences IncTrade
Plug Power IncTrade

Price performance (Past 24H)

Key statistics

Cassava Sciences Inc vs Plug Power Inc — how do they compare? Cassava Sciences Inc trades at $0.82 (market cap $39.40M), while Plug Power Inc trades at $1.75 (market cap $2.49B). The key difference: Plug Power Inc is far larger — about 63.2× Cassava Sciences Inc's market cap, and Cassava Sciences Inc is more actively traded (759,018 versus 47,846,349). Which is the better fit depends on your goals — on Pluang, investors hold Cassava Sciences Inc for 37 Days and Plug Power Inc for 41 Days on average.

FLNAPLUG
Market Cap
$39.40M$2.49B
Volume
759,01847,846,349
Sector
HealthIndustrials
52-Week High
$4.64$4.14
52-Week Low
$0.68$1.73
Typical Hold Time
37 Days41 Days
Enterprise Value
-$43.28M$3.36B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Cassava Sciences Inc

FLNA trades at $0.8136, down 7.01% today, with a bearish technical signal from moving averages. The company shows negative profitability with ROE at -55.79% and ROA at -35.34%, though it has beaten EPS estimates for three consecutive quarters. Recent FDA approval to lift the clinical hold on simufilam for epilepsy research provides a positive catalyst, with patient screening expected by Q1 2027.

Despite operational losses and negative cash flow, analyst consensus is bullish with 8 buy ratings versus 4 hold. The key investment opportunity lies in the clinical progress of simufilam, while risks include sustained cash burn and reliance on successful drug development outcomes in a competitive biotech landscape.

Plug Power Inc

Plug Power (PLUG) trades at $1.78, down 4.3% today, with a bearish technical outlook and negative earnings momentum. The company continues to report significant losses with a net income margin of -220.59% and negative cash flow, though recent news highlights strategic partnerships including a 280 MW electrolyzer agreement with Arcadia eFuels. Analyst consensus shows mixed sentiment with 44.7% buy ratings and a $3.13 price target, representing 76% upside potential from current levels.

While PLUG shows potential through hydrogen infrastructure expansion and recent contract wins, the investment case remains high-risk due to persistent negative profitability, cash burn, and competitive pressures. The stock trades near analyst low targets, suggesting limited downside protection, making it suitable only for speculative investors comfortable with substantial volatility and execution risk in the clean energy sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

FLNA
73% Buy27% Sell
Avg holding period · 37 Days
PLUG
75% Buy25% Sell
Avg holding period · 41 Days

Top news

Latest headlines on both assets

About Cassava Sciences Inc

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease

Read more on FLNA →

About Plug Power Inc

Plug Power is building an end-to-end green hydrogen ecosystem—from production, storage and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets—including material handling, e-mobility, power generation, and industrial applications.

Read more on PLUG →